Characterization of the severe phenotype of pyruvate kinase deficiency
Corresponding Author
Hanny Al-Samkari MD
Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Correspondence
Hanny Al-Samkari, MD, Division of Hematology, Massachusetts General Hospital, Zero Emerson Place Suite 118 Office 112, Boston, MA 02114.
Email: [email protected]
Search for more papers by this authorEduard J. van Beers MD, PhD
Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands
Search for more papers by this authorD. Holmes Morton MD
Central Pennsylvania Clinic for Special Children & Adults, Belleville, Pennsylvania
Lancaster General Hospital, Lancaster, Pennsylvania
Search for more papers by this authorWilma Barcellini MD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Search for more papers by this authorStefan W. Eber MD
Schwerpunktpraxis für Pädiatrische Hämatologie-Onkologie and Children's Hospital, Technical University, Munich, Germany
Search for more papers by this authorBertil Glader MD, PhD
Lucile Packard Children's Hospital, Stanford University, Palo Alto, California
Search for more papers by this authorHassan M. Yaish MD
Primary Children's Hospital, University of Utah, Salt Lake City, Utah
Search for more papers by this authorSatheesh Chonat MD
Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia
Search for more papers by this authorKevin H. M. Kuo MD
University of Toronto, University Health Network, Toronto, Ontario, Canada
Search for more papers by this authorJenny M. Despotovic DO
Texas Children's Hematology Center, Baylor College of Medicine, Houston, Texas
Search for more papers by this authorDagmar Pospíšilová MD, PhD
Fakultni nemocnice Olomouc, Olomouc, Czech Republic
Search for more papers by this authorChristine M. Knoll MD
Phoenix Children's Hospital, Phoenix, Arizona
Search for more papers by this authorJanet L. Kwiatkowski MD
Children's Hospital of Philadelphia and Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania
Search for more papers by this authorAlexis A. Thompson MD
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
Search for more papers by this authorMarcin W. Wlodarski MD
St. Jude Children's Research Hospital, Memphis, Tennessee
University of Freiburg, Freiburg, Germany
Search for more papers by this authorYaddanapudi Ravindranath MBBS
Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, Michigan
Search for more papers by this authorJennifer A. Rothman MD
Duke University Medical Center, Durham, North Carolina
Search for more papers by this authorHeng Wang MD, PhD
DDC Clinic for Special Needs Children, Middlefield, Ohio
Search for more papers by this authorSusanne Holzhauer MD
Charité University Medicine, Berlin, Germany
Search for more papers by this authorVicky R. Breakey MD
McMaster University, Hamilton, Ontario, Canada
Search for more papers by this authorMadeleine M. Verhovsek MD
McMaster University, Hamilton, Ontario, Canada
Search for more papers by this authorJoachim Kunz MD
Zentrum für Kinder-und Jugendmedizin, Heidelberg, Germany
Search for more papers by this authorSujit Sheth MD
Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York
Search for more papers by this authorMukta Sharma MD
Children's Mercy, University of Missouri Kansas City School of Medicine, Kansas City, Missouri
Search for more papers by this authorMelissa J. Rose DO
Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio
Search for more papers by this authorHeather A. Bradeen MD
The University of Vermont Children's Hospital, Burlington, Vermont
Search for more papers by this authorMelissa N. McNaull MD
University of Mississippi Medical Center, Jackson, Mississippi
Search for more papers by this authorKathryn Addonizio BA
Dana-Farber Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, Massachusetts
Search for more papers by this authorHasan Al-Sayegh MBChB, MPH
Dana-Farber Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, Massachusetts
Search for more papers by this authorWendy B. London PhD
Dana-Farber Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, Massachusetts
Search for more papers by this authorRachael F. Grace MD
Dana-Farber Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, Massachusetts
Search for more papers by this authorCorresponding Author
Hanny Al-Samkari MD
Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Correspondence
Hanny Al-Samkari, MD, Division of Hematology, Massachusetts General Hospital, Zero Emerson Place Suite 118 Office 112, Boston, MA 02114.
Email: [email protected]
Search for more papers by this authorEduard J. van Beers MD, PhD
Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands
Search for more papers by this authorD. Holmes Morton MD
Central Pennsylvania Clinic for Special Children & Adults, Belleville, Pennsylvania
Lancaster General Hospital, Lancaster, Pennsylvania
Search for more papers by this authorWilma Barcellini MD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Search for more papers by this authorStefan W. Eber MD
Schwerpunktpraxis für Pädiatrische Hämatologie-Onkologie and Children's Hospital, Technical University, Munich, Germany
Search for more papers by this authorBertil Glader MD, PhD
Lucile Packard Children's Hospital, Stanford University, Palo Alto, California
Search for more papers by this authorHassan M. Yaish MD
Primary Children's Hospital, University of Utah, Salt Lake City, Utah
Search for more papers by this authorSatheesh Chonat MD
Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia
Search for more papers by this authorKevin H. M. Kuo MD
University of Toronto, University Health Network, Toronto, Ontario, Canada
Search for more papers by this authorJenny M. Despotovic DO
Texas Children's Hematology Center, Baylor College of Medicine, Houston, Texas
Search for more papers by this authorDagmar Pospíšilová MD, PhD
Fakultni nemocnice Olomouc, Olomouc, Czech Republic
Search for more papers by this authorChristine M. Knoll MD
Phoenix Children's Hospital, Phoenix, Arizona
Search for more papers by this authorJanet L. Kwiatkowski MD
Children's Hospital of Philadelphia and Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania
Search for more papers by this authorAlexis A. Thompson MD
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
Search for more papers by this authorMarcin W. Wlodarski MD
St. Jude Children's Research Hospital, Memphis, Tennessee
University of Freiburg, Freiburg, Germany
Search for more papers by this authorYaddanapudi Ravindranath MBBS
Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, Michigan
Search for more papers by this authorJennifer A. Rothman MD
Duke University Medical Center, Durham, North Carolina
Search for more papers by this authorHeng Wang MD, PhD
DDC Clinic for Special Needs Children, Middlefield, Ohio
Search for more papers by this authorSusanne Holzhauer MD
Charité University Medicine, Berlin, Germany
Search for more papers by this authorVicky R. Breakey MD
McMaster University, Hamilton, Ontario, Canada
Search for more papers by this authorMadeleine M. Verhovsek MD
McMaster University, Hamilton, Ontario, Canada
Search for more papers by this authorJoachim Kunz MD
Zentrum für Kinder-und Jugendmedizin, Heidelberg, Germany
Search for more papers by this authorSujit Sheth MD
Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York
Search for more papers by this authorMukta Sharma MD
Children's Mercy, University of Missouri Kansas City School of Medicine, Kansas City, Missouri
Search for more papers by this authorMelissa J. Rose DO
Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio
Search for more papers by this authorHeather A. Bradeen MD
The University of Vermont Children's Hospital, Burlington, Vermont
Search for more papers by this authorMelissa N. McNaull MD
University of Mississippi Medical Center, Jackson, Mississippi
Search for more papers by this authorKathryn Addonizio BA
Dana-Farber Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, Massachusetts
Search for more papers by this authorHasan Al-Sayegh MBChB, MPH
Dana-Farber Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, Massachusetts
Search for more papers by this authorWendy B. London PhD
Dana-Farber Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, Massachusetts
Search for more papers by this authorRachael F. Grace MD
Dana-Farber Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, Massachusetts
Search for more papers by this author
Supporting Information
| Filename | Description |
|---|---|
| ajh25926-sup-0001-Supinfo.docxWord 2007 document , 13.8 KB | Table S1. Severity status of splenectomized patients with PK deficiency at three time-points (enrollment, first follow-up year, second follow-up year), for patients with known severity status at all three time-points (N = 116) |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Warang P, Kedar P, Ghosh K, Colah R. Molecular and clinical heterogeneity in pyruvate kinase deficiency in India. Blood Cells Mol Dis. 2013; 51(3): 133-137.
- 2Pissard S, Max-Audit I, Skopinski L, et al. Pyruvate kinase deficiency in France: a 3-year study reveals 27 new mutations. Br J Haematol. 2006; 133(6): 683-689.
- 3Grace RF, Bianchi P, van Beers EJ, et al. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study. Blood. 2018; 131(20): 2183-2192.
- 4Al-Samkari H, van Beers EJ, KHM K, et al. The variable manifestations of disease in pyruvate kinase deficiency and their management. Haematologica. 2020:haematol.2019.240846. https://doi.org/10.3324/haematol.2019.240846.
- 5Necheles TF, Finkel HE, Sheehan RG, Allen DM. Red cell pyruvate kinase deficiency. The effect of splenectomy. Arch Intern Med. 1966; 118(1): 75-78.
- 6Oski FA. Clinical consequences of enzyme deficiencies in the erythrocyte. Ann Clin Lab Sci. 1971; 1(2): 177-183.
- 7Vichinsky E. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management. Curr Med Res Opin. 2016; 32(1): 191-204.
- 8Al-Samkari H, Addonizio K, Glader B, et al. The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency. Br J Haematol. 2020. https://doi.org/10.1111/bjh.16724.
Citing Literature
